T‐cell surface generation of dual bivalent, bispecific T‐cell engaging, RNA duplex cross‐linked antibodies (dbBiTERs) for re‐directed tumor cell lysis-Reference-Cited by-同舟云学术

T‐cell surface generation of dual bivalent, bispecific T‐cell engaging, RNA duplex cross‐linked antibodies (dbBiTERs) for re‐directed tumor cell lysis

Published:2021-11-25 Issue:2 Volume:17 Page:2100389
ISSN:1860-6768
Container-title:Biotechnology Journal
language:en
Short-container-title:Biotechnology Journal

Author:

Kujawski Maciej¹,Li Lin¹,Li Harry¹,Yazaki Paul J.¹,Swiderski Piotr²,Shively John E.¹^ORCID

Affiliation:

1. Department of Immunology and Theranostics City of Hope Duarte California USA

2. Shared Resources‐DNA/RNA/Peptide City of Hope Duarte California USA

Funder

National Cancer Institute

Publisher

Wiley

Subject

Molecular Medicine,Applied Microbiology and Biotechnology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/biot.202100389

Reference41 articles.

1. Bispecific antibodies rise again

2. Bispecific antibodies: a mechanistic review of the pipeline

3. Blinatumomab, a Bispecific T-cell Engager (BiTE®) for CD-19 Targeted Cancer Immunotherapy: Clinical Pharmacology and Its Implications

4. A review of bispecific antibodies and antibody constructs in oncology and clinical challenges

5. Engineering therapeutic bispecific antibodies using CrossMab technology

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current challenges and therapeutic advances of CAR-T cell therapy for solid tumors;Cancer Cell International;2024-04-15

2. Clinical Applications of Combined Immunotherapy Approaches in Gastrointestinal Cancer: A Case-Based Review;Vaccines;2023-09-29

3. Immunotherapeutic Targeting of NG2/CSPG4 in Solid Organ Cancers;Vaccines;2022-06-26